Yunhui Cheng

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13”.

Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00384

N/A

0DataRank · unranked

75 citations

Yu Chang, Jean C. Tien, Zhen Wang, Yang Zhou, Pujuan Zhang +11 more

p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.29.587346

N/A

0DataRank · unranked

11 citations

Zhixiang Chen, Yuanyuan Qiao, Jean Ching-Yi Tien, Eleanor Young, Rahul Mannan +19 more

Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer

Nature Genetics(2025)10.1038/s41588-025-02336-6

N/A

0DataRank · unranked

19 citations

Zhixiang Chen, Yuanyuan Qiao, Jean C. Tien, Eleanor Young, Rahul Mannan +24 more